E114239 - ARI Artec Diagnosis AB
| Reference number | |
| Coordinator | Artec Diagnosis AB |
| Funding from Vinnova | SEK 1 131 874 |
| Project duration | September 2020 - August 2023 |
| Status | Completed |
| Venture | Eurostars |
Important results from the project
The formation of an Abdominal Aortic Aneurysm (AAA) is by far the most common aortic disease and its prevalence increases strongly with age. Optimal health care treatment of AAA patients critically depends on an AAA rupture risk assessment. ARI is a software platform that performs a patient-individual AAA rupture risk assessment using regularly taken CT images together with patient parameters, such as age, gender and medication history. The combination of Artificial Intelligence (AI) and vascular biomechanics simulation is greatly superior to any other risk assessment approach.
Expected long term effects
AAA patients are treated across one thousand vascular centers throughout Europe. The related health care market has a volume of two billion Euro per year. The majority of patients do not require costly treatment interventions, indicating the huge optimization potential of AAA treatment. ARI explores this business opportunity and offers a service-based business model.
Approach and implementation
By this Eurostars project a software platform that integrates geometrical, biomechanical and general patient data, towards an AI-based AAA rupture risk assessment could be developed. The raw data for such an analysis comes from regularly taken patient examinations readily available in AAA treating hospitals. The hospital can upload the patient data and receives an ARI report with 24 hours. Results have been presented at international medical conferences and meetings. Since July 2023 ARI is part of a big pilot managed by one of the largest medical device manufacturers in the world.